Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.
about
The meninges: new therapeutic targets for multiple sclerosis.Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesIntranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous systemNanotechnology Applications for Diffuse Intrinsic Pontine Glioma.Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats.Challenges and new strategies for therapeutic peptide delivery to the CNS.Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns).Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease.Alfalfa-derived HSP70 administered intranasally improves insulin sensitivity in mice.Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity.Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition.Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition.Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemiaOdor Sensitivity After Intranasal Insulin Application Is Modulated by Gender
P2860
Q35584727-3E840627-A672-41C9-8723-17838D088B50Q35768362-11154999-5044-4B27-86F4-79690F6DE3C6Q37248790-E0ED6D04-0526-44B8-BE37-2626126B679DQ37668050-5ED829EE-4163-4D3A-8B40-71A24B9C3A4CQ37729367-7BCF2A80-15EF-49DB-B50B-4F2A180D0FF7Q38358493-84F1B658-BC76-4F78-BD40-EAA0AC4527DDQ38558102-783129FB-AF6D-4327-9209-9FB35F33E736Q38750708-3FE21EFD-9BCD-4188-97B9-F475E534B23EQ42516901-DBF12427-9F5F-42CC-B070-A926C8BAAA54Q47932196-0E6A4F6A-4ADB-4F0B-BC8E-58AF2971F041Q47933830-9940F148-B524-4741-A498-7A1677416371Q48074126-644E5683-EA7A-4402-8882-6366E63DBDE6Q48299041-6FBAFFB9-15E2-4B06-9360-D2FA40DBEC52Q57292417-30D8E276-8730-4ED4-BE02-3E0F5053D564Q57818267-A0F3D486-7B81-463F-A7A2-7574F600B811
P2860
Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intranasal administration as a ...... a unique pathway for albumin.
@ast
Intranasal administration as a ...... a unique pathway for albumin.
@en
Intranasal administration as a ...... a unique pathway for albumin.
@nl
type
label
Intranasal administration as a ...... a unique pathway for albumin.
@ast
Intranasal administration as a ...... a unique pathway for albumin.
@en
Intranasal administration as a ...... a unique pathway for albumin.
@nl
prefLabel
Intranasal administration as a ...... a unique pathway for albumin.
@ast
Intranasal administration as a ...... a unique pathway for albumin.
@en
Intranasal administration as a ...... a unique pathway for albumin.
@nl
P2093
P2860
P356
P1476
Intranasal administration as a ...... a unique pathway for albumin.
@en
P2093
Alexander V Kabanov
Benjamin J Cordy
Joseph A Falcone
Therese S Salameh
William G Mortell
P2860
P356
10.1124/JPET.114.216705
P407
P577
2014-07-15T00:00:00Z